---
title: Effect of Glutamine Supplemented Nutrition Support on Protein and Glutamine Metabolism in Burns
nct_id: NCT00216996
overall_status: WITHDRAWN
sponsor: Massachusetts General Hospital
study_type: OBSERVATIONAL
primary_condition: Burns
countries: United States
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT00216996.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT00216996"
ct_last_update_post_date: 2016-11-16
last_seen_at: "2026-05-12T06:59:40.685Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Effect of Glutamine Supplemented Nutrition Support on Protein and Glutamine Metabolism in Burns

**Official Title:** Study on the Effect of Glutamine Supplemented Nutrition Support on Protein and Glutamine Metabolism in Severely Burned Patients

**NCT ID:** [NCT00216996](https://clinicaltrials.gov/study/NCT00216996)

## Key Facts

- **Status:** WITHDRAWN
- **Why Stopped:** This study was withdrawn (see NCT00181753).
- **Study Type:** OBSERVATIONAL
- **Target Enrollment:** 0
- **Lead Sponsor:** Massachusetts General Hospital
- **Conditions:** Burns
- **CT.gov Last Update:** 2016-11-16

## Brief Summary

The Total Parenteral Nutrition (TPN)received as part of your routine burn care has optimal levels of protein and sugar, however the best mixture of amino acids for a patient with burn wounds is not yet known. Amino acids occur naturally in the body and the food we eat. The body combines amino acids to make protein. It uses the proteins to do things such as heal wounds, fight infection, and provide energy. We are studying if the body's use of protein is increased after receiving TPN containing the amino acid called glutamine. We hope to learn the best composition of TPN so that the body can more efficiently repair wounded tissues and recover earlier from an acute burn injury.

## Detailed Description

Human and animal studies have demonstrated that glutamine catabolism exceeds glutamine synthesis in burn patients, resulting in a glutamine-depleted status, which compromises liver function, including glutathione status, proline and arginine homeostasis and whole body protein balance (1). The purpose of this study is to directly quantify glutamine / glutamate kinetics in relation to glutamine / glutamate disposal and whole body amino acid balance, by using stable isotope tracers \[1-13C, 15N\]leucine and \[15N2\]urea.

We hypothesize that the enrichment of amino acid mixtures with glutamine will attenuate overall body nitrogen catabolism and better maintain proline and arginine homeostasis.

The purpose of this study it to 1) investigate the effect of glutamine supplemented total parenteral nutrition (TPN) on whole body metabolic and disposal rate of glutamine, and its rate of de novo synthesis in severely burned patients and 2)explore the impact of glutamine supplementation on whole body protein turnover, studied with L-\[1-13C, 15N}-leucine, and on the metabolic homeostasis of urea cycle.

## Eligibility

- **Minimum age:** 18 Years
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

Burn patients being treated at MGH Burn Unit with one or more of the following criteria: 1) \>=5% TBSA; 2) inhalation injury; or 3) resting energy expenditure (REE) of \>15% of the predicted Basal Metabolic Rate using the Harris-Benedict equation.

Must be receiving total parenteral nutrition in the course of their treatment.

Exclusion Criteria:

Patients with thyroid disease. Patients who are not hemodynamically stable or show unstable vital signs Patients at the stage of major organ failure, e.g. renal and/or liver failure.
```

## Arms

- **Burn patients** — Receiving standard TPN with or without glutamine enrichment

## Primary Outcomes

- **This is a study for measuring the protein kinetics for metabolism of the amino acid glutamine. Kinetics will be derived from measurements on blood and air samples taken as part of the study.** _(time frame: 15 hours)_

## Locations (1)

- Massachusetts General Hospital Burn Unit, Boston, Massachusetts, United States

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.whyStopped` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.massachusetts general hospital burn unit|boston|massachusetts|united states` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT00216996.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT00216996*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*